The FDA announced on July 24, 2025, that Boston Scientific Corporation is recalling ENDOTAK RELIANCE G/SG with 4-SITE Connector transvenous defibrillation leads due to a Class I hazard. The affected devices may experience gradually rising LVSI measurements associated with calcification of the lead coils. This issue can lead to early lead replacement and potentially death or the need for cardiac resuscitation.
How to tell if you have it
- Brand: Boston Scientific
- Product: ENDOTAK RELIANCE G/SG with 4-SITE Connector, transvenous defibrillation lead, Permanent Defibrillator Electrodes
- Model Nos.: 0282, 0283, 0285, 0286, 0292, 0293, 0295, 0296
- UPCs: 00802526431371, 00802526431388, 00802526431401, 00802526431418, 00802526431432, 00802526431449, 00802526431463, 00802526431470, 00802526504396, 00802526531248, 00802526531279, 00802526541988, 00802526554490, 00802526554506, 00802526611131
- Distribution: Worldwide
The hazard
According to the FDA, affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. The most serious harm reported is death or the need for cardiac resuscitation.
Context
GovInfoNow's records show Boston Scientific Corporation has 124 other recalls on record since June 1, 2017. Other recent recalls include the Imager II Angiographic Catheters Recall (Aug. 24, 2026) for tip fracture risk and the LUX-Dx Cardiac Monitor System Recall (Aug. 6, 2026) for delayed AF burden alerts. Additional recent recalls involve StoneSmart Connect Console Power Adapters (July 22, 2026), INFINION CX Lead Kits (June 17, 2026), CSK Electrodes (April 29, 2026), and Inspire Respiratory Sensing Lead Model 4340 (May 11, 2026).